Drug screening is examining samples such as urine, breath, oral fluid, hair, and other bodily fluids for the presence of compounds that exceed the legal limit. The importance of drug testing is because a person under the influence of drugs or alcohol is more likely to cause accidents on the road and in the workplace. Drug screening tests are available from companies like Abbott Laboratories for use in the workplace, government agencies, rehabilitation clinics, and other locations. These tests are non-invasive and painless. Furthermore, manufacturers such as Alere, Inc. (part of Abbott Laboratories) offer drug screening point-of-care diagnostic tests. Additionally, drug addicts in specific professions, such as air traffic controllers and commercial drivers, can jeopardise the safety of others, which can be averted with pre-employment urine testing. Drug testing could also assist to cut down on on-the-job accidents. A urine drug test is painless and looks for prescription drugs such amphetamines, methamphetamines, benzodiazepines, marijuana, barbiturates, cocaine, methadone, and opioids in the pee (narcotics). Furthermore, drug and alcohol treatment facilities must test residents on a regular basis to guarantee that they are sober. Technological advancements such as immunoassay techniques for drug screening, and rapid point of care tests have fostered growth of the drug screening market.
The expansion of the drug screening market is being aided by competition among top manufacturers in the industry. Manufacturers are working on new items in a variety of sectors in order to maintain their market leadership. In 2017, Alere, Inc. and its partner business GenPrime, Inc. developed the xReader, a point-of-care testing device for workplace drug testing. In 2017, Alere, Inc. launched Alere iCup Rx drug screen for detecting commonly misused and abused prescription drugs. Moreover, technological advancements are expected to boost growth of the drug screening market over the forecast period. For example, Intelligent Fingerprinting Limited launched non-invasive portable fingerprint drug test in 2017.
Furthermore, rising traffic accident rates due to drunk driving or driving after drug usage are likely to propel the drug screening market forward over the forecast period.. For example, five Michigan counties launched pilot roadside drug testing in November 2017, which used Alere DDS2 oral fluid test instrument to detect marijuana, opioids, and other drugs. Moreover, Captiva Lab launched an oral fluid drug testing integrated with mass spectrometry to include an oral fluid test panel in 2017. Additionally, rising demand from a wide range of locations where drug testing may be necessary, such as workplaces, hospitals, and rehabilitation facilities, is likely to propel the drug screening market forward over the forecast period. In May of 2018, Phenomenex, Inc. introduced Strata-X-Drug B Plus, a solid phase extraction (SPE) sample preparation product for urine drug testing. However, ban of alcohol and drugs at workplace and government organizations, and increasing awareness against driving under influence is expected to hinder the growth of the drug screening market.
Because of the presence of key manufacturers such as Alere, Inc., North America and Europe are likely to dominate the drug screening market over the projection period. Mergers and acquisitions by important companies, such as Abbott Laboratories’ acquisition of Alere, Inc. in 2017, are projected to fuel market expansion. Asia Pacific region is expected to witness significant growth over the forecast period, owing to increasing presence of leading manufacturers in the region. For instance, Alere Medical Pvt. Ltd. launched integrated facility in India for manufacturing rapid point of care diagnostic devices in 2016. The company intends to make India an export hub for rapid diagnostic devices in Asia Pacific region.
Get PDF Brochure of this report
Key players operating in the global drug screening market include Thermo Fisher Scientific, Quest Diagnostics, Omega Laboratories, Abbott Laboratories, Danaher Corporation, Express Diagnostics International Inc., Siemens Healthineers, Alfa Scientific Designs, F. Hoffmann La Roche, SureHire, and OraSure.
Drug Screening Market Taxonomy-
The global drug screening market is segmented on the basis of product type, application, end user, and region.
By Product Type-
- Immunoassay analyzers
- Chromatography Instruments
- Drug testing Cups
- Dip Cards
- Oral Fluid Testing Products
By Application –
- Urine Testing
- Breath Testing
- Oral Fluid Testing
- Hair Testing
By End User –
- Rehabilitation Centers
- Drug Testing Laboratories
By Region –
- North America
- Asia Pacific
- Latin America
- Middle East
Buy This Complete Business Report
Table of Content
Global Drug Screening Market Research Report
Section 1: Global Drug Screening Industry Overview
Section 2: Global Economic Impact on Drug Screening Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Drug Screening Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Drug Screening Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027